Nanocarriers as an emerging platform for cancer therapy

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781

Multidrug resistance in cancer: role of ATP–dependent transporters

Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536

Recent advances with liposomes as pharmaceutical carriers

Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282

Cancer nanotechnology: opportunities and challenges

Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558

Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance

Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., & West, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232479100 · Cited by 3,961

Nanoparticles in cancer therapy and diagnosis

Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,040

Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment

Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438

World Cancer Report

Stewart, B. W., & Kleihues, P. (2003) · Cited by 2,389

Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model

Arap, W., Pasqualini, R., & Ruoslahti, E. I. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,040

Polymer conjugates as anticancer nanomedicines

Duncan, R. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1958 · Cited by 1,956

Micellar Nanocarriers: Pharmaceutical Perspectives

Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910

Immunotargeted Nanoshells for Integrated Cancer Imaging and Therapy

Loo, C. H., Lowery, A. R., Halas, N. J., West, J. L., & Drezek, R. A. (2005) · Nano Letters · doi:10.1021/nl050127s · Cited by 1,792

Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.

Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,706

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,667

Ligand-targeted therapeutics in anticancer therapy

Allen, T. M. (2002) · Nature reviews. Cancer · doi:10.1038/nrc903 · Cited by 1,648

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Papahadjopoulos, D., Allen, T. M., Gabizón, A., Mayhew, E. G., Matthay, K. K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasiç, D. D., & Redemann, C. T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,621

Dendrimers and dendritic polymers in drug delivery

Gillies, E. R., & Fréchet, J. M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03276-3 · Cited by 1,361

Small-scale systems for in vivo drug delivery

LaVan, D. A., McGuire, T., & Langer, R. (2003) · Nature Biotechnology · doi:10.1038/nbt876 · Cited by 1,314

Dendrimers:

Malik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J.-W., Meijer, E. W., Paulus, W., & Duncan, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00246-1 · Cited by 1,228

Barriers to Drug Delivery in Solid Tumors

Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,074

Nanotechnology: Intelligent Design to Treat Complex Disease

Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 992

Gold Nanocages: Bioconjugation and Their Potential Use as Optical Imaging Contrast Agents

Chen, J., Saeki, F., Wiley, B. J., Cang, H., Cobb, M. J., Li, Z., Au, L., Zhang, H., Kimmey, M. B., Li, X. D., et al. (2005) · Nano Letters · doi:10.1021/nl047950t · Cited by 977

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

Sengupta, S., Eavarone, D. A., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 946

Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.

Haran, G., Cohen, R., Bar, L. K., & Barenholz, Y. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90105-9 · Cited by 934

Nanoparticle Targeting of Anticancer Drug Improves Therapeutic Response in Animal Model of Human Epithelial Cancer

Kukowska‐Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3921 · Cited by 912

Improving the efficacy of antibody-based cancer therapies

Carter, P. M. (2001) · Nature reviews. Cancer · doi:10.1038/35101072 · Cited by 849

Polymersomes

Discher, D. E., & Ahmed, F. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095838 · Cited by 844

Cancer Facts & Figures 2004

Betts, P., Mokry, B., Risser, D. R., Weiss, N. S., Williams, M. A., Sjoberg, E., Clanton, M. S., Frankel, L. S., Foxhall, L. E., Hancock, L. E., et al. (2004) · Cited by 840

Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles.

Sokolov, K., Follen, M. M., Aaron, J., Pavlova, I., Malpica, A. L., Lotan, R., & Richards-Kortum, R. R. (2003) · PubMed · Cited by 838

Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines

Calvo, P., Remuñán‐López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012128907225 · Cited by 823

Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆

Farokhzad, O. C., & Langer, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.011 · Cited by 802

Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain

Nord, K., Gunneriusson, E., Ringdahl, J., Ståhl, S., Uhlén, M., & Nygren, P. (1997) · Nature Biotechnology · doi:10.1038/nbt0897-772 · Cited by 663

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G. T., Shalaby, R., Baselga, J. M., Shao, Y. Y., Nielsen, U. B., Marks, J. D., Moore, D. H., et al. (2002) · PubMed · Cited by 652

Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin

Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602204 · Cited by 623

High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.

Adams, G. P., Schier, R., McCall, A. M., Simmons, H. H., Horak, E. M., Alpaugh, R. K., Marks, J. D., & Weiner, L. M. (2001) · PubMed · Cited by 623

Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2

Safra, T., Muggia, F. M., Jeffers, S., Tsao-Wei, D. D., Groshen, S. G., Lyass, O., Henderson, R., Berry, G. J., & Gabizón, A. (2000) · Annals of Oncology · doi:10.1023/a:1008365716693 · Cited by 618

VEGF as a Therapeutic Target in Cancer

Ferrara, N. (2005) · Oncology · doi:10.1159/000088479 · Cited by 587

The Binding Avidity of a Nanoparticle-Based Multivalent Targeted Drug Delivery Platform

Hong, S., Leroueil, P. R., Majoros, I., Orr, B. G., Baker, J. R., & Holl, M. M. B. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.11.015 · Cited by 585

Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor

Lee, E. S., Na, K., & Bae, Y. H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.018 · Cited by 577

Development of the polymer micelle carrier system for doxorubicin

Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00341-8 · Cited by 570

Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy

Gabizón, A. (2001) · Cancer Investigation · doi:10.1081/cnv-100103136 · Cited by 568

Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates

Trail, P. A., Willner, D., Lasch, S. J., Henderson, A. J., Hofstead, S. J., Casazza, A. M., Firestone, R. A., Hellström, I., & Hellström, K. E. (1993) · Science · doi:10.1126/science.8327892 · Cited by 557

Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura

Arnold, D. M., Dentali, F., Crowther, M. A., Meyer, R. M., Cook, R. J., Sigouin, C. S., Fraser, G. A. M., Lim, W., & Kelton, J. G. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-1-200701020-00006 · Cited by 551

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

Lee, K. S., Chung, H. C., Im, S. A., Park, Y. H., Kim, C. S., Kim, S.-B., Rha, S. Y., Lee, M. Y., & Ro, J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9591-y · Cited by 541

Immunotoxin therapy of cancer

Pastan, I. H., Hassan, R., FitzGerald, D. J., & Kreitman, R. J. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1891 · Cited by 529

Metal Nanoshells

Hirsch, L. R., Gobin, A. M., Lowery, A. R., Tam, F., Drezek, R. A., Halas, N. J., & West, J. L. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-9001-8 · Cited by 516

The biological chemistry of folate receptors

Antony, A. (1992) · Blood · doi:10.1182/blood.v79.11.2807.2807 · Cited by 477

Facile Synthesis of Gold−Silver Nanocages with Controllable Pores on the Surface

Chen, J., McLellan, J. M., Siekkinen, A. R., Xiong, Y., Li, Z., & Younan Xia, A. (2006) · Journal of the American Chemical Society · doi:10.1021/ja066023g · Cited by 452

Long-circulating (sterically stabilized) liposomes for targeted drug delivery

Allen, T. M. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90314-x · Cited by 447

Ligand-targeted liposomal anticancer drugs

Sapra, P., & Allen, T. M. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00032-8 · Cited by 447

Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.

Goren, D., Horowitz, A. T., Tzemach, D., Tarshish, M., Zalipsky, S., & Gabizón, A. (2000) · PubMed · Cited by 402

Efficient Cancer Therapy with a Nanobody-Based Conjugate

Cortez‐Retamozo, V., Backmann, N., Senter, P. D., Wernery, U., BAETSELIER, P. D., Muyldermans, S., & Revets, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3935 · Cited by 383

Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer

Danson, S., Ferry, D., Alakhov, V, Margison, J., Kerr, D., Jowle, D., Brampton, M., Halbert, G., & Ranson, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601856 · Cited by 382

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470

Satchi‐Fainaro, R., Puder, M., Davies, J. W., Tran, H. T., Sampson, D. A., Greene, A. K., Corfas, G., & Folkman, J. (2004) · Nature Medicine · doi:10.1038/nm1002 · Cited by 345

Advancing the field of drug delivery

Moses, M. A., Brem, H., & Langer, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00276-9 · Cited by 344

Shrinkage of a Rapidly Growing Tumor by Drug-Loaded Polymersomes: pH-Triggered Release through Copolymer Degradation

Ahmed, F., Pakunlu, R. I., Srinivas, G., Brannan, A. K., Bates, F. S., Klein, M. L., Minko, T., & Discher, D. E. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050103u · Cited by 330

Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.

Eliaz, R. E., & Szoka, F. C. (2001) · PubMed · Cited by 330

Nanomedicines for overcoming biological barriers

Alonso, M. J. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.01.007 · Cited by 312

A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells

Wong, H. L., Rauth, A. M., Bendayan, R., Manias, J. L., Ramaswamy, M., Liu, Z., Erhan, S. Z., & Wu, X. Y. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0282-x · Cited by 303

Developing aptamers into therapeutics

White, R. R., Sullenger, B. A., & Rusconi, C. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11325 · Cited by 297

Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1

Peer, D., Zhu, P., Carman, C. V., Lieberman, J., & Shimaoka, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608491104 · Cited by 276

Pros and Cons of the Liposome Platform in Cancer Drug Targeting

Gabizón, A., Shmeeda, H., & Zalipsky, S. (2006) · Journal of Liposome Research · doi:10.1080/08982100600848769 · Cited by 272

Randomized Phase II Study of BR96-Doxorubicin Conjugate in Patients With Metastatic Breast Cancer

Tolcher, A. W., Sugarman, S. M., Gelmon, K. A., Cohen, R., Saleh, M. N., Isaacs, C. J., Young, L., Healey, D. I., Onetto-Pothier, N., & Slichenmyer, W. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.478 · Cited by 271

Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia (‘hand-foot’ syndrome)

Lorusso, D., Stefano, A. D., Carone, V., Fagotti, A., Pisconti, S., & Scambia, G. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl477 · Cited by 263

In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.

de Menezes, D. E. L., Pilarski, L. M., & Allen, T. M. (1998) · PubMed · Cited by 260

Liposomes Bearing Polyethyleneglycol-Coupled Transferrin with Intracellular Targeting Property to the Solid Tumors In Vivo

Ishida, O., Maruyama, K., Tanahashi, H., Iwatsuru, M., Sasaki, K., Eriguchi, M., & Yanagië, H. (2001) · Pharmaceutical Research · doi:10.1023/a:1010960900254 · Cited by 258

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature

Halin, C., Rondini, S., Nilsson, F., Berndt, A., Kosmehl, H., Zardi, L., & Neri, D. (2002) · Nature Biotechnology · doi:10.1038/nbt0302-264 · Cited by 249

Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs.

Sapra, P., & Allen, T. M. (2002) · PubMed · Cited by 242

Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet.

Gabizón, A. (2001) · PubMed · Cited by 236

Loading mitomycin C inside long circulating hyaluronan targeted nano‐liposomes increases its antitumor activity in three mice tumor models

Peer, D., & Margalit, R. (2003) · International Journal of Cancer · doi:10.1002/ijc.11615 · Cited by 229

Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity

Batrakova, E., Dorodnych, T. Y., Klinskii, E., Kliushnenkova, E., Шемчукова, О. Б., Goncharova, O., Arjakov, S., Alakhov, V., & Kabanov, A. V. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.587 · Cited by 228

Targeted contrast agents for magnetic resonance imaging and ultrasound

Morawski, A. M., Lanza, G., & Wickline, S. A. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.11.001 · Cited by 223

Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded Nanoparticles

Couvreur, P., Kante, B., Grislain, L., Roland, M., & Speiser, P. P. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710717 · Cited by 217

Intracellular targeting therapy of cisplatin‐encapsulated transferrin‐polyethylene glycol liposome on peritoneal dissemination of gastric cancer

Iinuma, H., Maruyama, K., Okinaga, K., Sasaki, K., Sekine, T., Ishida, O., Ogiwara, N., Johkura, K., & Yonemura, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10242 · Cited by 216

Tumor-Targeted Hyaluronan Nanoliposomes Increase the Antitumor Activity of Liposomal Doxorubicin in Syngeneic and Human Xenograft Mouse Tumor Models

Peer, D., & Margalit, R. (2004) · Neoplasia · doi:10.1593/neo.03460 · Cited by 214

A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats

Garcion, E., Lamprecht, A., Heurtault, B., Paillard, A., Aubert‐Pouëssel, A., Denizot, B., Meneï, P., & Benoît, J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0289 · Cited by 213

Nanotechnology for biomaterials engineering: structural characterization of amphiphilic polymeric nanoparticles by 1H NMR spectroscopy

Hrkach, J. S., Peracchia, M. T., Bomb, A., Lotan, N., & Langer, R. (1997) · Biomaterials · doi:10.1016/s0142-9612(96)00077-4 · Cited by 206

Human Antibody Fragments Specific for Human Blood Group Antigens from a Phage Display Library

Marks, J. D., Ouwehand, W. H., Bye, J. M., et al. (1993) · Nature Biotechnology · doi:10.1038/nbt1093-1145 · Cited by 202

Monoclonal Antibody Therapy for Cancer

von Mehren, M., Adams, G. P., & Weiner, L. M. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152442 · Cited by 191

Adsorption of Antineoplastic Drugs to Polyalkylcyanoacrylate Nanoparticles and Their Release in Calf Serum

Couvreur, P., Kante, B., Roland, M., et al. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600681215 · Cited by 186

Polymer–drug conjugates: towards a novel approach for the treatment of endrocine-related cancer

Duncan, R., Vicent, M. J., Greco, F., & Nicholson, R. I. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01045 · Cited by 179

Tissue Distribution of Antitumor Drugs Associated with Polyalkylcyanoacrylate Nanoparticles

Couvreur, P., Kante, B., Lenaerts, V., et al. (1980) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600690222 · Cited by 152

Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer

Albanell, J., & Baselga, J. (1999) · Drugs of today · doi:10.1358/dot.1999.35.12.564040 · Cited by 142

Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains

Silverman, J., Lu, Q., Bakker, A., To, W., Duguay, A. N., Alba, B. M., Smith, R., Rivas, A., Li, P., Le, H., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1166 · Cited by 137

Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma

Akechi, T., Okamura, H., Nishiwaki, Y., & Uchitomi, Y. (2001) · Cancer · doi:10.1002/1097-0142(20011115)92:10 · Cited by 119

Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model

Hu, Z., Sun, Y. H., & Garen, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8161 · Cited by 100

Mapping Tumor Epitope Space by Direct Selection of Single-Chain Fv Antibody Libraries on Prostate Cancer Cells

Liu, B., Conrad, F., Cooperberg, M. R., Kirpotin, D. B., & Marks, J. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2732 · Cited by 93

Immunoliposomes for cancer therapy.

Kontermann, R. E. (2006) · PubMed · Cited by 91

New approaches to antibody therapy

Weiner, L. M., & Adams, G. P. (2000) · Oncogene · doi:10.1038/sj.onc.1204000 · Cited by 89

Fluoxetine and reversal of multidrug resistance

Peer, D., & Margalit, R. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.06.003 · Cited by 85

Recent Developments in Polymeric Nanoparticle Engineering and Their Applications in Experimental and Clinical Oncology

Moghimi, S. M. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006778699130 · Cited by 74

Targeting of RGD‐modified proteins to tumor vasculature: A pharmacokinetic and cellular distribution study

Schraa, A. J., Kok, R. J., Moorlag, H. E., Bos, E. J., Proost, J. H., Meijer, D. K. F., de Leij, L. F. M. H., & Molema, G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10727 · Cited by 73

Reconstituted collagen nanoparticles, a novel drug carrier delivery system

El-Samaligy, M. S., & Rohdewald, P. J. (1983) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1983.tb04831.x · Cited by 70

Levels of 5-hydroxymethyl-2′-deoxyuridine in DNA from blood as a marker of breast cancer

Djurić, Z., Heilbrun, L. K., Simon, M. S., Smith, D. W., Luongo, D. A., LoRusso, P. M., & Martino, S. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960215)77:4 · Cited by 60

Polymer Therapeutics II

Satchi‐Fainaro, R., & Duncan, R. (2005) · Advances in polymer science · doi:10.1007/11547785 · Cited by 56

Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein

Matsuo, H., Wakasugi, M., Takanaga, H., et al. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00460-6 · Cited by 48

Distribution of the transferrin receptor in normal human fibroblasts and fibrosarcoma cells

Ekblom, P., Thesleff, I., Lehto, V., & Virtanen, I. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910310118 · Cited by 48

Synthesis of Alginic Acid−Poly[2-(diethylamino)ethyl methacrylate] Monodispersed Nanoparticles by a Polymer−Monomer Pair Reaction System

Guo, R., Zhang, L., Jiang, Z., Cao, Y., Ding, Y., & Jiang, X. (2007) · Biomacromolecules · doi:10.1021/bm060906i · Cited by 47

Differential transferrin receptor density in human colorectal cancer: A potential probe for diagnosis and therapy.

Prost, A., Ménégaux, F., Langlois, P., Vidal, J. M., Koulibaly, M., Jost, J. L., Duron, J. J., Jp, C., Vayre, P., Aurengo, A., et al. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.4.871 · Cited by 46

Attempted targeting of a monoclonal antibody in a human tumour xenograft system

Warenius, H. M., Galfré, G., Bleehen, N. M., et al. (1981) · European Journal of Cancer and Clinical Oncology · doi:10.1016/s0277-5379(81)80006-5 · Cited by 41

Fusion protein from RGD peptide and Fc fragment of mouse immunoglobulin G inhibits angiogenesis in tumor

Li, J., Ji, J., Holmes, L. M., Burgin, K. E., Barton, L. B., Yu, X., Wagner, T. E., & Wei, Y. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700707 · Cited by 34

Improved Delivery of Methoxsalen

Kreuter, J., & Higuchi, T. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600680415 · Cited by 24

Cell adhesion and tumor metastasis.

Ruoslahti, E. I. (1994) · PubMed · Cited by 23

Phase I study of NK105, a paclitaxel-incorporating micellar nanoparticle, in patients with advanced cancer

Kato, K., Hamaguchi, T., Yasui, H., Okusaka, T., Ueno, H., Ikeda, M., Shirao, K., Shimada, Y., Nakahama, H., Muro, K., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.2018 · Cited by 19

Polymer therapeutics : polymers as drugs, conjugates and gene delivery systems

Duncan, R., Satchi‐Fainaro, R., Alakhov, V. Y., et al. (2006) · Springer eBooks · Cited by 14

Selection of Internalizing Antibodies for Drug Delivery

Marks, J. D. (2004) · Humana Press eBooks · doi:10.1385/1-59259-666-5:201 · Cited by 14

Cancer nanomedicine: progress, challenges and opportunities

Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873

Analysis of nanoparticle delivery to tumours

Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218

Clinical development and potential of photothermal and photodynamic therapies for cancer

Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456

Progress and challenges towards targeted delivery of cancer therapeutics

Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220

Endocytosis of nanomedicines

Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181

pH-sensitive nanocarriers for curcumin delivery in cancer therapy

Mohammadzadeh, V., Zirak, M. R., Hosseinikhah, S. M., Kamali, H., & Jaafari, M. R. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102879 · Cited by 21

Reduction-sensitive polymeric nanocarriers in cancer therapy: a comprehensive review

Deng, B., Ma, P., & Xie, Y. (2015) · Nanoscale · doi:10.1039/c5nr02878g · Cited by 136

Recent advances in near-infrared light-responsive nanocarriers for cancer therapy

Saneja, A., Kumar, R., Arora, D., Kumar, S., Panda, A. K., & Jaglan, S. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.02.005 · Cited by 111

Pharmaceutical Nanocarriers (Liposomes and Micelles) in Cancer Therapy

Vaze, O. S. (2016) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000e138 · Cited by 18

Polymeric nanocarriers incorporating near-infrared absorbing agents for potent photothermal therapy of cancer

Zhang, Y., Ang, C. Y., & Zhao, Y. (2015) · Polymer Journal · doi:10.1038/pj.2015.117 · Cited by 81